Publication | Closed Access

Inhibition of miR-155 alleviates sepsis-induced inflammation and intestinal barrier dysfunction by inactivating NF-κB signaling

InflammationChronic Inflammatory DiseasesMucosal ImmunologyImmune Cell DevelopmentImmune RegulationImmunologyPathologySepsisChronic InflammationImmune FunctionInnate ImmunityIntestinal MicrobiotaGut BarrierImmune SystemMedicineInflammatory DiseaseIntestinal Barrier DysfunctionNf-κb Signaling